Dwarfism, Pituitary: all 171 studies
Page 1 of 2. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- Charactertizing Growth Hormone Deficiency in Traumatic Brain InjuryRecruitingNCT07795736
- GB06 Phase III Trial for Pediatric Growth Hormone DeficiencyRecruitingNCT07553351Phase 3
- Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone DeficiencyRecruitingNCT07551804Phase 2
- REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)RecruitingNCT07412782Not applicable
- Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 LevelsNot yet recruitingNCT07173036Not applicable
- Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone DeficiencyNot yet recruitingNCT07129759Phase 3
- Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone DeficiencyNot yet recruitingNCT07126288Phase 2/3
- A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)RecruitingNCT07016802Phase 1
- Phase 3 Study of LUM-201 in Children With Growth Hormone DeficiencyRecruitingNCT06948214Phase 3
- A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical ParametersEnrolling by invitationNCT06709040
- BELux Children OutcoME During A(@)Dulthood With GHDRecruitingNCT06694506Not applicable
- A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.RecruitingNCT06587035
- Use of miRNAs in Growth Hormone Deficiency (GHD)RecruitingNCT06455956
- A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFARecruitingNCT05820672
- A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)Enrolling by invitationNCT05796440Phase 2
- A Post-Authorisation Safety Study (PASS) of Patients Treated With LonapegsomatropinRecruitingNCT05775523
- A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety InformationEnrolling by invitationNCT05718570
- Effects of GH and Lirglutide on AgRPRecruitingNCT05681299Phase 4
- The AgRP and GH/IGF-1 Axis in ChildrenNot yet recruitingNCT05645211
- Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)RecruitingNCT05355272Phase 2
- Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)RecruitingNCT04867317Phase 3
- Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short StatureRecruitingNCT04798690
- Growth Hormone Replacement Therapy for Retried Professional Football PlayersRecruitingNCT04121780Phase 2
- Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of TherapyRecruitingNCT03053687Not applicable
- Chromosome 18 Clinical Research CenterRecruitingNCT00227253
- Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)CompletedNCT05250063Phase 2Results posted
- A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone DeficiencyCompletedNCT05171855Phase 3Results posted
- A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone DeficiencyCompletedNCT04615273Phase 3Results posted
- Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)CompletedNCT04614337Phase 2Results posted
- Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone DeficiencyCompletedNCT03874013Phase 3Results posted
- Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHDCompletedNCT03831880Phase 3Results posted
- A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical TrialCompletedNCT03344458Phase 3Results posted
- A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone DeficiencyCompletedNCT03305016Phase 3Results posted
- Body Composition and Adipose Tissue in HIVTerminatedNCT03226821Phase 4Results posted
- A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone DeficiencyCompletedNCT03075644Phase 3Results posted
- A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)CompletedNCT02781727Phase 3Results posted
- Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)TerminatedNCT02719990Phase 2Results posted
- Validation of Macimorelin as a Test for Adult Growth Hormone DeficiencyCompletedNCT02558829Phase 3Results posted
- A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone DeficiencyCompletedNCT02382939Phase 3Results posted
- Long-Acting Growth Hormone in Children Compared to Daily rhGHCompletedNCT02339090Phase 3Results posted
- A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone DeficiencyCompletedNCT02311894Phase 4Results posted
- Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.CompletedNCT02229851Phase 3Results posted
- Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)CompletedNCT01947907Phase 2Results posted
- A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) PatientsCompletedNCT01947894Results posted
- A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone DeficiencyTerminatedNCT01909479Phase 3Results posted
- An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)CompletedNCT01806298Phase 4Results posted
- The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic AxisCompletedNCT01282164Not applicableResults posted
- A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone DeficiencyCompletedNCT01247675Phase 2Results posted
- Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity StudyTerminatedNCT01237340Phase 3Results posted
- Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®CompletedNCT01187550Phase 4Results posted
- Comparison of a Needle-free Injection Method With a Needle-syringe Injection MethodCompletedNCT00990340Phase 4Results posted
- Adult Growth Hormone Deficiency and Cardiovascular RiskTerminatedNCT00720902Phase 4Results posted
- Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk FactorsTerminatedNCT00684957Phase 1/2Results posted
- Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone DeficiencyTerminatedNCT00630487Phase 3Results posted
- Drug Use Investigation of Somatropin for GHD-ADULTS.CompletedNCT00601419Results posted
- Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary TrialCompletedNCT00591760Phase 2Results posted
- Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain InjuryTerminatedNCT00555009Phase 4Results posted
- Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®CompletedNCT00256126Phase 4Results posted
- Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone DeficiencyCompletedNCT00191165Phase 3Results posted
- Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone DeficiencyCompletedNCT00182091Not applicableResults posted
- Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve HypoplasiaCompletedNCT00140413Phase 4Results posted
- Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone DeficiencyCompletedNCT00109733Phase 3Results posted
- Testosterone and Growth Hormone for Bone Loss in MenCompletedNCT00080483Phase 2Results posted
- Hypothalamic-Stratified Nursing Pathway for Pediatric CraniopharyngiomaCompletedNCT07342686
- A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)TerminatedNCT07259564Phase 2
- Development of a Personalized Growth Hormone Treatment Profile (PGTP) Report for Pediatric EndocrinologyCompletedNCT06830525
- Evaluation of the Propensity of Patients Under rhGH to Envision a Modification of Their Treatment Regimen Toward LAGHCompletedNCT06542809Not applicable
- Biological Age in Children With GH Deficiency Undergoing Hormone Replacement TherapyCompletedNCT06294860
- A Study to Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth HormoneWithdrawnNCT06113952
- Vesiculogenesis in Children With GH Deficiency (VESCIGHTP)Active, not recruitingNCT05759624
- Growth Hormone Deficiency in Mild Traumatic Brain InjuryStatus unknownNCT05660356Early Phase 1
- Ngenla Subcutaneous Injection Special InvestigationActive, not recruitingNCT05602766
- Isolated Growth Hormone Deficiency and AmennorrheaCompletedNCT05448924
- Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®Active, not recruitingNCT05230550
- PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212)Active, not recruitingNCT04806854Phase 2
- A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it isCompletedNCT04786873Phase 3
- A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone DeficiencyCompletedNCT04633057Phase 3
- Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency ChildrenCompletedNCT04513171Phase 2/3
- Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone DeficiencyStatus unknownNCT04326374Phase 3
- Skeletal Muscle Effects of GH in BoysCompletedNCT04020913
- Neuropsychological Assessment of Children and Adolescents With Turner SyndromeCompletedNCT03812913
- Treatment of GHD Associated With CHFStatus unknownNCT03775993Phase 3
- Development and Validation of a Self-assessment System Based on a Mobile App to Manage Adult Growth Hormone DeficiencyCompletedNCT03525587Not applicable
- Evalutation of Insulin Sensitivity Through Hyperinsulinemic Clamp in Children With GH DeficiencyCompletedNCT03525171Not applicable
- Growth and Asymmetric diMethylArginineCompletedNCT03422081
- Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone DeficiencyCompletedNCT03309891Phase 2
- Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone DeficiencyStatus unknownNCT03249480Phase 4
- Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone DeficiencyCompletedNCT03223025Phase 3
- Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function.CompletedNCT03212131Phase 1
- Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal FunctionCompletedNCT03186495Phase 1
- A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone DeficiencyTerminatedNCT03145831Phase 3
- The Primordial Dwarfisms: Diagnosis, Identification of the Molecular Basis of Seckel Syndrome and Microcephalic Osteodysplastic Primordial Dwarfism Type IICompletedNCT03139903
- A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHDStatus unknownNCT03104010Phase 2
- Diagnosing Adult Growth Hormone DeficiencyCompletedNCT03018886Not applicable
- Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone DeficiencyStatus unknownNCT02976675Phase 4
- A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9CompletedNCT02946606Phase 2
- Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone DeficiencyStatus unknownNCT02908958Phase 4
- Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone DeficiencyCompletedNCT02693522Phase 3
- Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)CompletedNCT02580032
- Versartis International Trial in Adults With Long-Acting Growth HormoneCompletedNCT02526420Phase 2